WHO Issues Guidance for Use of Casirivimab-Imdevimab in COVID-19
Combo conditionally recommended for patients with nonsevere disease at risk for severe disease, seronegative patients with severe infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.